Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (270)
Lexeo Therapeutics, Inc. (LXEO)
Tamayo Louis Edward — Chief Financial Officer
Shares
4,641
Price
$4.49
Total Value
$20.84K
Shares Held After
97,024
% of Holdings
4.6%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
700
Price
$52.13
Total Value
$36.49K
Shares Held After
73,389
% of Holdings
0.9%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
8,300
Price
$51.46
Total Value
$427.13K
Shares Held After
74,089
% of Holdings
10.1%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
171,429
Price
$5.53
Total Value
$948.00K
Shares Held After
354,535
% of Holdings
32.6%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
3,057
Price
$1.93
Total Value
$5.90K
Shares Held After
15,492
% of Holdings
19.7%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,438
Price
$15.02
Total Value
$36.61K
Shares Held After
0
% of Holdings
100.0%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
2,438
% of Holdings
50.0%
Beam Therapeutics Inc. (BEAM)
Simon Amy — Chief Medical Officer
Shares
373
Price
$34.73
Total Value
$12.95K
Shares Held After
102,363
% of Holdings
0.4%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
6,566
Price
$14.00
Total Value
$91.92K
Shares Held After
8,617
% of Holdings
43.2%
Legend Biotech Corp (LEGN)
Casey Patrick John — Director
Shares
6,000
Price
$14.80
Total Value
$88.80K
Shares Held After
48,604
% of Holdings
11.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
4,654
Price
$20.00
Total Value
$93.08K
Shares Held After
51,776
% of Holdings
8.2%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
101,050
Price
$21.12
Total Value
$2.13M
Shares Held After
308,504
% of Holdings
24.7%
Shattuck Labs, Inc. (STTK)
Shukla Abhinav A. — Chief Technical Officer
Shares
23,365
Price
$7.08
Total Value
$165.42K
Shares Held After
86,380
% of Holdings
21.3%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
600
Price
$57.09
Total Value
$34.25K
Shares Held After
40,000
% of Holdings
1.5%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
29,400
Price
$56.44
Total Value
$1.66M
Shares Held After
40,600
% of Holdings
42.0%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
2,554
Price
$57.10
Total Value
$145.84K
Shares Held After
459,399
% of Holdings
0.6%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
97,446
Price
$56.50
Total Value
$5.51M
Shares Held After
461,953
% of Holdings
17.4%
Shattuck Labs, Inc. (STTK)
Pandite Arundathy N. — Chief Medical Officer
Shares
30,000
Price
$7.01
Total Value
$210.30K
Shares Held After
136,219
% of Holdings
18.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
100
Price
$2.50
Total Value
$250.00
Shares Held After
2,559,875
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
25,930
Price
$2.54
Total Value
$65.86K
Shares Held After
2,559,775
% of Holdings
1.0%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
50,000
Price
$19.09
Total Value
$954.50K
Shares Held After
225,857
% of Holdings
18.1%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
10,000
Price
$34.90
Total Value
$349.00K
Shares Held After
42,963
% of Holdings
18.9%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
55
Price
$1.54
Total Value
$84.70
Shares Held After
72,590
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
545
Price
$1.54
Total Value
$839.30
Shares Held After
718,989
% of Holdings
0.1%
Pyxis Oncology, Inc. (PYXS)
Dupont Jakob — Director
Shares
35,000
Price
$3.06
Total Value
$107.10K
Shares Held After
38,741
% of Holdings
47.5%
ABEONA THERAPEUTICS INC. (ABEO)
Alland Leila — Director
Shares
11,000
Price
$5.92
Total Value
$65.09K
Shares Held After
162,614
% of Holdings
6.3%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
5,681
Price
$70.00
Total Value
$397.67K
Shares Held After
9,756
% of Holdings
36.8%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
3,200
Price
$117.70
Total Value
$376.65K
Shares Held After
244,883
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
6,153
Price
$116.99
Total Value
$719.86K
Shares Held After
248,083
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
7,971
Price
$115.82
Total Value
$923.18K
Shares Held After
254,236
% of Holdings
3.0%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
51,375
Price
$114.77
Total Value
$5.90M
Shares Held After
262,207
% of Holdings
16.4%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
4,110
Price
$114.19
Total Value
$469.31K
Shares Held After
313,582
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,100
Price
$112.79
Total Value
$124.07K
Shares Held After
317,692
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,700
Price
$111.57
Total Value
$189.66K
Shares Held After
318,792
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,500
Price
$110.54
Total Value
$165.81K
Shares Held After
320,492
% of Holdings
0.5%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
28,826
Price
$16.04
Total Value
$462.29K
Shares Held After
139,372
% of Holdings
17.1%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
115,844
Price
$45.50
Total Value
$5.27M
Shares Held After
2,555,877
% of Holdings
4.3%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
115,844
Price
$45.50
Total Value
$5.27M
Shares Held After
2,555,877
% of Holdings
4.3%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
17,060
Price
$46.43
Total Value
$792.10K
Shares Held After
25,996
% of Holdings
39.6%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
4,107
Price
$46.49
Total Value
$190.93K
Shares Held After
25,996
% of Holdings
13.6%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
20,000
Price
$46.40
Total Value
$928.00K
Shares Held After
148,235
% of Holdings
11.9%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
10,000
Price
$46.46
Total Value
$464.60K
Shares Held After
168,235
% of Holdings
5.6%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,255
Price
$24.98
Total Value
$106.29K
Shares Held After
41,688
% of Holdings
10.2%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,638
Price
$23.88
Total Value
$39.12K
Shares Held After
37,433
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,910
Price
$22.95
Total Value
$43.83K
Shares Held After
35,795
% of Holdings
5.3%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
25,027
Price
$17.13
Total Value
$428.79K
Shares Held After
9,212,252
% of Holdings
0.3%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
30,703
Price
$35.49
Total Value
$1.09M
Shares Held After
93,969
% of Holdings
24.6%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
27,872
Price
$35.48
Total Value
$988.89K
Shares Held After
58,750
% of Holdings
32.2%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
10,833
Price
$16.02
Total Value
$173.59K
Shares Held After
8,961
% of Holdings
54.7%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
10,000
Price
$16.01
Total Value
$160.08K
Shares Held After
17,217
% of Holdings
36.7%
Showing 101–150 of 270 transactions (page 3 of 6)